[HTML][HTML] Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
C Zhang, Y Wang, Y Zhu, C Liu, C Gu… - Nature …, 2021 - econpapers.repec.org
The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
[PDF][PDF] Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
C Zhang, Y Wang, Y Zhu, C Liu, C Gu, S Xu, Y Wang… - researchgate.net
MAbs. We attempted to generate SARS-CoV-2-neutralizing MAbs from mice immunized with
a recombinant protein containing the SARS-CoV-2 RBD fused with a C-terminal mouse IgG …
a recombinant protein containing the SARS-CoV-2 RBD fused with a C-terminal mouse IgG …
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
C Zhang, Y Wang, Y Zhu, C Liu, C Gu, S Xu… - Nature …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The ongoing pandemic of coronavirus disease
2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS …
2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS …
[HTML][HTML] Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
C Zhang, Y Wang, Y Zhu, C Liu, C Gu, S Xu… - Nature …, 2021 - ncbi.nlm.nih.gov
The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
C Zhang, Y Wang, Y Zhu, C Liu, C Gu… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections.
C Zhang, Y Wang, Y Zhu, C Liu, C Gu… - Nature …, 2021 - search.ebscohost.com
The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
C Zhang, Y Wang, Y Zhu, C Liu, C Gu, S Xu… - Nature …, 2021 - ideas.repec.org
The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections.
C Zhang, Y Wang, Y Zhu, C Liu, C Gu, S Xu… - Nature …, 2021 - europepmc.org
The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS …
[PDF][PDF] Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
C Zhang, Y Wang, Y Zhu, C Liu, C Gu, S Xu, Y Wang… - scienceopen.com
MAbs. We attempted to generate SARS-CoV-2-neutralizing MAbs from mice immunized with
a recombinant protein containing the SARS-CoV-2 RBD fused with a C-terminal mouse IgG …
a recombinant protein containing the SARS-CoV-2 RBD fused with a C-terminal mouse IgG …